What is the management for a patient with suspected local anesthetic toxicity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Local Anesthetic Systemic Toxicity (LAST)

Immediately stop local anesthetic administration, call for help, secure the airway with 100% oxygen, and administer 20% intravenous lipid emulsion (1.5 mL/kg bolus over 1 minute followed by 0.25 mL/kg/min infusion) while providing standard resuscitation—this is the definitive life-saving intervention for LAST. 1, 2

Immediate Recognition and Initial Actions

Stop the local anesthetic immediately upon suspecting LAST and call for help—do not delay treatment while confirming the diagnosis. 2, 3

Airway and Breathing Management

  • Secure the airway and administer 100% oxygen via non-rebreather mask, high-flow nasal cannula, or endotracheal intubation if necessary. 1, 2
  • Intubate the trachea if the patient cannot protect their airway or has severe respiratory compromise. 1
  • Ventilate with 100% oxygen to maximize oxygenation, as hypoxia and acidosis worsen local anesthetic toxicity. 1

Seizure Management

  • Administer benzodiazepines immediately for seizures—this is the first-line treatment for LAST-induced seizures. 1
  • Avoid propofol in large doses as it can worsen cardiovascular depression in LAST. 4
  • Seizure suppression is critical because seizures increase oxygen consumption and worsen acidosis, which potentiates local anesthetic toxicity. 4

Lipid Emulsion Therapy: The Definitive Treatment

Administer 20% intravenous lipid emulsion immediately for cardiovascular collapse or severe symptoms:

  • Initial bolus: 1.5 mL/kg over 1 minute (approximately 100 mL for a 70 kg adult). 1, 2
  • Continuous infusion: 0.25 mL/kg/min immediately after the bolus. 1, 2
  • Repeat bolus: If cardiovascular stability is not restored, repeat the 1.5 mL/kg bolus and increase infusion to 0.5 mL/kg/min. 1
  • Maximum cumulative dose: Approximately 10 mL/kg over the first 30 minutes. 1

Lipid emulsion creates a lipid compartment in serum that sequesters lipophilic local anesthetics away from cardiac tissue and increases cardiac inotropy. 1

Cardiovascular Management

For Wide-Complex Tachycardia

  • Administer sodium bicarbonate (1-2 mEq/kg IV) for life-threatening wide-complex tachycardia associated with local anesthetic toxicity. 1
  • Sodium bicarbonate helps reverse sodium channel blockade caused by local anesthetics. 1

For Bradycardia

  • Administer atropine (0.5-1 mg IV for adults) for life-threatening bradycardia. 1
  • Repeat every 3-5 minutes as needed up to maximum 3 mg. 1

For Hypotension and Cardiovascular Collapse

  • Start CPR immediately if cardiac arrest occurs, following Advanced Life Support guidelines. 1
  • Use small doses of epinephrine (<1 mcg/kg) if needed—avoid standard ACLS doses as large doses of epinephrine may worsen outcomes in LAST. 4
  • Avoid vasopressin as it may impair the effectiveness of lipid emulsion therapy. 4
  • Administer rapid IV crystalloid bolus (1-2 liters normal saline or lactated Ringer's solution) for hypotension. 1

Refractory Cardiovascular Collapse

  • Consider VA-ECMO (veno-arterial extracorporeal membrane oxygenation) for refractory cardiogenic shock unresponsive to lipid emulsion and standard resuscitation. 1, 2
  • Communicate early with perfusion team for possible cardiopulmonary bypass if cardiovascular collapse persists. 4

Monitoring During Resuscitation

  • Continuous ECG monitoring is essential as cardiovascular signs represent late manifestations of toxicity, especially in anesthetized patients. 2
  • Monitor for resedation or recurrent symptoms, as local anesthetics have prolonged effects. 3
  • Continue monitoring vital signs until complete resolution of symptoms. 5

Critical Pitfalls to Avoid

Do not use propofol for seizure control in large doses—it worsens cardiovascular depression in LAST. 4

Do not use standard ACLS epinephrine doses—use small doses (<1 mcg/kg) as large doses may impair lipid emulsion effectiveness and worsen outcomes. 4

Do not delay lipid emulsion therapy—administer as soon as LAST is suspected with cardiovascular symptoms, not after failed standard resuscitation. 1, 2

Do not assume the diagnosis is wrong if initial lipid therapy fails—repeat boluses and increase infusion rate may be needed. 1

Post-Resuscitation Care

  • Transfer to ICU or appropriate critical care area for continued monitoring, even if symptoms resolve. 1
  • Observe for at least 4-6 hours after symptom resolution, as recurrent toxicity can occur with long-acting local anesthetics. 3
  • Document exact timing of local anesthetic administration, dose, route, symptom onset, all treatments administered, and patient response. 5, 6

Prevention Strategies

  • Use ultrasound guidance for regional anesthesia to reduce risk of intravascular injection. 3
  • Aspirate before injection to check for blood return. 3
  • Use the minimal effective dose of local anesthetic. 2, 3
  • Administer local anesthetics in fractionated doses rather than single large boluses. 1
  • Monitor continuously during and after local anesthetic administration. 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Local Anesthetic Systemic Toxicity

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Local anesthetic systemic toxicity: A narrative review for emergency clinicians.

The American journal of emergency medicine, 2022

Research

Treatment of local anesthetic systemic toxicity (LAST).

Regional anesthesia and pain medicine, 2010

Guideline

Anaphylaxis Management in Outpatient Settings

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Delayed Hypersensitivity Reactions After Anesthesia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.